Skip to main page content

Sunir J. Garg, MD, FACS, FASRS

Participates in 5 items

Sunir J. Garg, MD, is Professor of Ophthalmology at the Retina Service of Wills Eye Hospital, Thomas Jefferson University, and is a partner with Mid Atlantic Retina.  He is co-director of the Retina Research Unit at Wills Eye Hospital.  He has published more than 400 peer reviewed papers, book chapters, and commentaries, and is editor of ophthalmology for the Merck Manual, Deputy Editor in Chief of the American Academy of Ophthalmology ONE Network, outgoing Editor-in-Chief of Retina Times, and a member of the Editorial Boards of the American Journal of Ophthalmology and the Canadian Journal of Ophthalmology.  He is also an official clinical spokesperson for the American Academy of Ophthalmology.

Dr. Garg has been featured in the Wall Street Journal, USA Today, the Philadelphia Inquirer, Popular Science, The Atlantic, Women’s Health, and has been on Good Morning America, the Today Show, and the Canadian Broadcasting Corporation.


Financial disclosure: Dr. Garg has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Apellis
  2. Bausch & Lomb
  3. Boehringer lngelheim 
  4. Coherus
  5. Genentech
  6. Kanaph
  7. Kodiak Biosciences
  8. Merck Manual
  9. NGM Bio
  10. Regeneron



Sessions in which Sunir J. Garg, MD, FACS, FASRS participates

Sunday 27 June, 2021

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
11:00 AM
11:00 AM - 12:30 PM | 1 hour 30 minutes
Current Concepts

Learning ObjectivesAt the end of this session, participants will be able to: List key issues in managing patients with glaucoma and corneal transplantsDescribe the “Value Proposition” of glaucoma management from the Patient’s PerspectiveReview vision screening options for stroke admissions through the pathway from emergency department to dischargeDescribe the ocular manifestation of Zika and Ebola infe...

12:05 PM
12:07 PM - 12:15 PM | 8 minutes
Current Concepts
3:15 PM
3:15 PM - 4:45 PM | 1 hour 30 minutes

Learning ObjectivesAt the end of this session, participants are able to:Describe new advances in macular degeneration with geographic atrophy, neovascular macular degeneration and diabetic retinopathyIntegrate multi-modal imaging in the management of retinal detachment repairAssess the impact of COVID-19 on retinal practicesCanMEDS Roles: Medical Expert, Scholar

3:16 PM - 3:35 PM | 19 minutes
4:25 PM